TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9549713

Group type: EXPERIMENTAL
Intervention: Dynamic range of motion (DROM) training, performed 5 days a week for 6 weeks, involving active movement into knee extension and holding the position.
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Static stretch, performed 5 days a week for 6 weeks, consisting of one 30-second static stretch.
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group, no stretching performed.
Number of subjects: 58
Study: 7638926

Group type: EXPERIMENTAL
Intervention: Artroflow device
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group (Heparin and physical methods)
Number of subjects: 95
Study: 2692823

Group type: EXPERIMENTAL
Intervention: Erythromycin ethylsuccinate (2 gm daily)
Number of subjects: 750

Group type: COMPARATOR
Intervention: Clavulanate‐potentiated amoxicillin (1.125 gm daily)
Number of subjects: 750
Study: 778655

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Levodopa
Number of subjects: 12
Study: 31042621

Group type: EXPERIMENTAL
Intervention: 10 Hz rTMS intervention (n = 40)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Sham stimulation (n = 40)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (waiting list, no treatment, n = 25)
Number of subjects: 105
Study: 28403269

Group type: EXPERIMENTAL
Intervention: CPM®‐26 (Cohesive Polydensified Matrix®)
Number of subjects: 45

Group type: COMPARATOR
Intervention: VYC®‐20 (VYCROSS®)
Number of subjects: 45
Study: 26063507

Group type: EXPERIMENTAL
Intervention: Aerobic training (3 months)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (educational programme + breathing exercises)
Number of subjects: 58
Study: 22964882

Group type: EXPERIMENTAL
Intervention: Gemtuzumab ozogamicin (GO) at a dose of 5 mg on day 1 of each course of low-dose Ara-C (LDAC)
Number of subjects: 495

Group type: COMPARATOR
Intervention: Low-dose Ara-C (LDAC) alone
Number of subjects: 495
Study: 22040189

Group type: EXPERIMENTAL
Intervention: Atomoxetine (ATX) at a target dose of 1.2 mg/kg/day for 8 weeks
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 19402154

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (75 mg/day for 2 months)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 16469979

Group type: EXPERIMENTAL
Intervention: Low-fat diet (LFD) (17% of energy from fat)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Moderate-fat diet (MFD) (34% of energy from fat)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Logistic regression model with trans 18:1, 18:2n-6, and vaccenic acid (18:1n-7)
Number of subjects: 66
Study: 15258716

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 17364300

Group type: EXPERIMENTAL
Intervention: Training group (148 women)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Control group (153 women)
Number of subjects: 301
Study: 11254229

Group type: EXPERIMENTAL
Intervention: 24% oxygen (oxygen enrichment)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ambient air (control)
Number of subjects: 24
Study: 8875537

Group type: EXPERIMENTAL
Intervention: Enteral formula supplemented with arginine, omega‐3 fatty acids, and nucleotides (A)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Standard enteral formula (B)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Low calorie/low fat intravenous solution (C)
Number of subjects: 41
Study: 2003854

Group type: EXPERIMENTAL
Intervention: Deflazacort
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 26

Group type: COMPARATOR
Intervention: Neither corticosteroid
Number of subjects: 26
Study: 6340444

Group type: EXPERIMENTAL
Intervention: Intravenous diazepam (5 mg)
Number of subjects: 284

Group type: COMPARATOR
Intervention: No diazepam (Control)
Number of subjects: 284
Study: 31859559

Group type: EXPERIMENTAL
Intervention: Collision with a person announcement
Number of subjects: 664

Group type: COMPARATOR
Intervention: Emergency services announcement
Number of subjects: 664
Study: 28236984

Group type: EXPERIMENTAL
Intervention: LY2510924 + carboplatin/etoposide (LY+SOC)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Carboplatin/etoposide alone (SOC)
Number of subjects: 94
Study: 26812001

Group type: EXPERIMENTAL
Intervention: Multivitamin supplementation
Number of subjects: 239
Study: 24255767

Group type: EXPERIMENTAL
Intervention: MRI observations at RTP
Number of subjects: 53
Study: 22855917

Group type: EXPERIMENTAL
Intervention: Modified hypocaloric diet (MHCD) with high-protein, low-glycemic load (30% of daily energy from protein)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional hypocaloric diet (CHCD) (15% of daily energy from protein)
Number of subjects: 60
Study: 20718543

Group type: EXPERIMENTAL
Intervention: Countercultural norms emphasizing nurturing the less capable in the United States
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Countercultural norms emphasizing competitive achievement in the Netherlands
Number of subjects: 0
Study: 17694344

Group type: EXPERIMENTAL
Intervention: c9,t11-18:2
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: t10,c12-18:2
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (olive oil)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: c9,t11-18:2 and t10,c12-18:2
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Body fatness
Number of subjects: 12
Study: 15867002

Group type: EXPERIMENTAL
Intervention: Antioxidant treatment (1 g vitamin C and 1 g vitamin E daily for 2 months)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 12236630

Group type: EXPERIMENTAL
Intervention: 3 million units subcutaneous IFN-alpha
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9808216

Group type: EXPERIMENTAL
Intervention: High-fat diet (HF) with dexfenfluramine (DF)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Low-fat diet (LF) with dexfenfluramine (DF)
Number of subjects: 6

Group type: COMPARATOR
Intervention: High-fat diet (HF) with placebo (PL)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Low-fat diet (LF) with placebo (PL)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Dexfenfluramine (DF)
Number of subjects: 6
Study: 7569514

Group type: EXPERIMENTAL
Intervention: Recombinant hirudin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bayesian population pharmacokinetic/pharmacodynamic model
Number of subjects: 0
Study: 2666137

Group type: EXPERIMENTAL
Intervention: Totally implanted access systems (TI)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Classical external catheters (CE)
Number of subjects: 96
Study: 31881911

Group type: EXPERIMENTAL
Intervention: Multimodal manual therapy (MT) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care by the general practitioner (GP)
Number of subjects: 0
Study: 29850922

Group type: EXPERIMENTAL
Intervention: Intensified multifactorial intervention
Number of subjects: 160

Group type: COMPARATOR
Intervention: Conventional multifactorial intervention
Number of subjects: 160
Study: 26891118

Group type: EXPERIMENTAL
Intervention: Iodine supplementation (150 μg of iodine as potassium iodate daily for 24 weeks)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Iodine supplementation
Number of subjects: 112
Study: 24055845

Group type: COMPARATOR
Intervention: Apixaban
Number of subjects: 14897

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 14897

Group type: EXPERIMENTAL
Intervention: High-sensitivity troponin T (hs‐TnT) levels
Number of subjects: 14897

Group type: EXPERIMENTAL
Intervention: hs‐TnT quartiles
Number of subjects: 14897

Group type: EXPERIMENTAL
Intervention: hs‐TnT levels added to CHA2DS2VASc score
Number of subjects: 14897
Study: 23027488

Group type: EXPERIMENTAL
Intervention: Stand-alone anchored spacers (group A, n=23)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Anterior plate (group B, n=28)
Number of subjects: 51
Study: 19125778

Group type: EXPERIMENTAL
Intervention: Alogliptin 12.5 mg
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Alogliptin 25 mg
Number of subjects: 500

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Alogliptin 12.5 mg and 25 mg
Number of subjects: 500
Study: 17493152

Group type: EXPERIMENTAL
Intervention: LTA 252GG genotype
Number of subjects: 0

Group type: COMPARATOR
Intervention: LGALS2 polymorphism
Number of subjects: 0
Study: 16198981

Group type: EXPERIMENTAL
Intervention: Nimorazole
Number of subjects: 320

Group type: COMPARATOR
Intervention: Nimorazole (high osteopontin concentration)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Placebo (low osteopontin concentration)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Placebo (intermediate osteopontin concentration)
Number of subjects: 320
Study: 12421198

Group type: EXPERIMENTAL
Intervention: REM with propofol
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: REM with desflurane
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: REM with sevoflurane
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional anesthetic (thiopentone, alfentanil, isoflurane, N2O)
Number of subjects: 120
Study: 10522993

Group type: EXPERIMENTAL
Intervention: Ibandronate infusion (dosage not specified)
Number of subjects: 315
Study: 8569226

Group type: EXPERIMENTAL
Intervention: metoprolol
Number of subjects: 34

Group type: COMPARATOR
Intervention: sotalol
Number of subjects: 34
Study: 1952135

Group type: EXPERIMENTAL
Intervention: Esmolol (1.0 mg/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Labetalol (0.3 mg/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fentanyl (1.5 micrograms/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Lidocaine (1.0 mg/kg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline solution (control)
Number of subjects: 10
Study: 7150394

Group type: EXPERIMENTAL
Intervention: Experimental diet (vegetarianism)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control diet (usual intake in the U.S.A.)
Number of subjects: 15
Study: 31414891

Group type: EXPERIMENTAL
Intervention: Presence of any of 10 CT features for complicated appendicitis
Number of subjects: 100

Group type: COMPARATOR
Intervention: Gestalt assessment by radiologists
Number of subjects: 100
Study: 28551197

Group type: EXPERIMENTAL
Intervention: Vitamin C + sodium bicarbonate
Number of subjects: 160

Group type: COMPARATOR
Intervention: Sodium bicarbonate alone
Number of subjects: 160
Study: 25327828

Group type: EXPERIMENTAL
Intervention: FeNO-guided algorithm
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 0
Study: 23419340

Group type: EXPERIMENTAL
Intervention: Desflurane (group Des)
Number of subjects: 332
Study: 21826541

Group type: EXPERIMENTAL
Intervention: 6-week internet-based prevention program (icd-forum.de)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Internet-based psychosocial care
Number of subjects: 0
Study: 19321528

Group type: EXPERIMENTAL
Intervention: Trapeziectomy with Flexor carpi radialis ligament reconstruction, tendon interposition and Kirschner wire insertion followed by splintage for 6 weeks (T+LRTI)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Excision of the trapezium with no Kirschner wire and immobilisation of the thumb in a soft bandage for only 3 weeks (T)
Number of subjects: 128
Study: 17709710

Group type: EXPERIMENTAL
Intervention: TCH346 (1.0, 2.5, 7.5, or 15 mg/day)
Number of subjects: 591

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 591

Group type: EXPERIMENTAL
Intervention: TCH346
Number of subjects: 591
Study: 14722031

Group type: EXPERIMENTAL
Intervention: Obese men
Number of subjects: 42

Group type: COMPARATOR
Intervention: Lean men
Number of subjects: 42
Study: 11847921

Group type: EXPERIMENTAL
Intervention: Insecticide-treated bednets
Number of subjects: 0

Group type: COMPARATOR
Intervention: House spraying with deltamethrin
Number of subjects: 0
Study: 10456137

Group type: COMPARATOR
Intervention: Oxygen injector
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Mechanical ventilation (Ohmedia 7000 ventilator)
Number of subjects: 46
Study: 8042757

Group type: EXPERIMENTAL
Intervention: flunitrazepam/fentanyl (0.01 mg/kg for induction, 1.2 mg/h for maintenance)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: etomidate (0.25 mg/kg) and fentanyl (0.005 mg/kg) for induction, isoflurane (0.6‐1.2 vol%)/fentanyl (1.2 mg/h) for maintenance
Number of subjects: 30

Group type: COMPARATOR
Intervention: Not applicable (control group)
Number of subjects: 30
Study: 3381314

Group type: EXPERIMENTAL
Intervention: Chloroquine sulphate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amodiaquine hydrochloride
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fansidar
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no antimalarial agents)
Number of subjects: 0
Study: 28695977

Group type: EXPERIMENTAL
Intervention: Hybrid coronary revascularization (HCR)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 200
Study: 27906104

Group type: EXPERIMENTAL
Intervention: Computer-based mindfulness intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 0
Study: 24400937

Group type: EXPERIMENTAL
Intervention: Motivational intervention (MI)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Brief advice (BA)
Number of subjects: 140
Study: 22623383

Group type: COMPARATOR
Intervention: Standard formula (4 mg iron/L, 13.1 g protein/L)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: α‐Lactalbumin-enriched infant formula (α‐LAC)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: α‐Lactalbumin-enriched/casein‐glycomacropeptide‐reduced infant formula (α‐LAC/RGMP)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Breast milk
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Formula-fed infants with iron deficiency
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Formula-fed infants
Number of subjects: 31
Study: 20837163

Group type: EXPERIMENTAL
Intervention: Web-based hypertension feedback
Number of subjects: 500

Group type: COMPARATOR
Intervention: Web-based preventive health feedback
Number of subjects: 500
Study: 17848393

Group type: EXPERIMENTAL
Intervention: ramipril (5 mg BID)
Number of subjects: 528

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 528
Study: 16392975

Group type: EXPERIMENTAL
Intervention: Motivational enhancement therapy plus cognitive-behavioral (MET-CB) treatment
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Motivational enhancement therapy (MET)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Delayed treatment control group
Number of subjects: 450
Study: 12399280

Group type: EXPERIMENTAL
Intervention: Iodine intake estimated by food‐frequency questionnaire
Number of subjects: 4649

Group type: EXPERIMENTAL
Intervention: Iodine intake from diet plus supplements
Number of subjects: 4649

Group type: EXPERIMENTAL
Intervention: Iodine intake from diet/kg body weight
Number of subjects: 4649

Group type: EXPERIMENTAL
Intervention: Milk intake
Number of subjects: 4649

Group type: EXPERIMENTAL
Intervention: Urinary iodine excretion measured as a concentration
Number of subjects: 4649

Group type: EXPERIMENTAL
Intervention: All measures of iodine intake
Number of subjects: 4649

Group type: EXPERIMENTAL
Intervention: Some measures of iodine intake
Number of subjects: 4649
Study: 10467958

Group type: EXPERIMENTAL
Intervention: H2‐receptor antagonist (n = 196)
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor (n = 116)
Number of subjects: 312
Study: 7826063

Group type: EXPERIMENTAL
Intervention: UFT combined therapy group (UFT, DESP, and castration)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Hormonal therapy alone group (DESP and castration)
Number of subjects: 92
Study: 1369703

Group type: EXPERIMENTAL
Intervention: Nicardipine (60 mg daily)
Number of subjects: 1736
Study: 6996626

Group type: EXPERIMENTAL
Intervention: Intravenous metronidazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral metronidazole
Number of subjects: 0
Study: 30816732

Group type: EXPERIMENTAL
Intervention: Pain management program with clinician support
Number of subjects: 397
Study: 27759074

Group type: EXPERIMENTAL
Intervention: 200 mg or 400 mg γδ‐T3 emulsions
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 26026286

Group type: EXPERIMENTAL
Intervention: Bromocriptine therapy (2.5 mg b.i.d. for 14 days and 2.5 mg q.d. from day 15 to 56) plus best supportive care (BSC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Best supportive care (BSC) plus 1 week of low-dose bromocriptine (2.5 mg q.d.) with anticoagulant therapy at a prophylactic dose
Number of subjects: 60

Group type: COMPARATOR
Intervention: Both groups (Bromocriptine and control)
Number of subjects: 60
Study: 23375680

Group type: EXPERIMENTAL
Intervention: DPP-IV inhibitors (sitagliptin and vildagliptin)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Vildagliptin
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: DPP-IV inhibitors
Number of subjects: 90
Study: 20553148

Group type: EXPERIMENTAL
Intervention: Amoxicillin antibiotic prophylaxis
Number of subjects: 100

Group type: COMPARATOR
Intervention: Different amoxicillin regimens
Number of subjects: 100
Study: 19436275

Group type: EXPERIMENTAL
Intervention: H. pylori eradication group receiving 1-week triple therapy (n=105)
Number of subjects: 325

Group type: COMPARATOR
Intervention: H. pylori-positive non-eradication controls (n=105)
Number of subjects: 325

Group type: COMPARATOR
Intervention: H. pylori-negative controls (n=115)
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: H. pylori eradication group
Number of subjects: 325
Study: 16750246

Group type: EXPERIMENTAL
Intervention: Duloxetine 80 mg
Number of subjects: 1133

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1133
Study: 14993498

Group type: EXPERIMENTAL
Intervention: Citrate-taurolidine-containing solution
Number of subjects: 58

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 58
Study: 11240235

Group type: EXPERIMENTAL
Intervention: Long-term hormones (LTH) - goserelin starting the last week of RT and continued indefinitely.
Number of subjects: 993

Group type: COMPARATOR
Intervention: Short-term hormones (STH) - goserelin and flutamide 2 months prior to and during RT.
Number of subjects: 993

Group type: COMPARATOR
Intervention: Radiation therapy (RT) alone.
Number of subjects: 993
Study: 9512280

Group type: EXPERIMENTAL
Intervention: Pure cut current
Number of subjects: 170

Group type: COMPARATOR
Intervention: Blended current
Number of subjects: 170
Study: 8070927

Group type: EXPERIMENTAL
Intervention: 100 mg fluconazole orally over 5 days
Number of subjects: 23

Group type: COMPARATOR
Intervention: 100 mg fluconazole for 10-21 days
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: 100 mg fluconazole
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: C. albicans isolates
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Candida spp. other than C. albicans
Number of subjects: 23
Study: 3281775

Group type: EXPERIMENTAL
Intervention: 5 mg inhaled diltiazem
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 10 mg inhaled diltiazem
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 15 mg inhaled diltiazem
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 30 mg inhaled diltiazem
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 60 mg inhaled diltiazem
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High-dose diltiazem (20 to 45 mg)
Number of subjects: 10
Study: 31059836

Group type: EXPERIMENTAL
Intervention: CephX® online website-based platform
Number of subjects: 30

Group type: COMPARATOR
Intervention: FACAD® computer software
Number of subjects: 30
Study: 28965646

Group type: EXPERIMENTAL
Intervention: Airtraq® optical laryngoscope
Number of subjects: 80

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 80
Study: 27692976

Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg once daily for 5 days
Number of subjects: 22
Study: 25608582

Group type: EXPERIMENTAL
Intervention: Deep breathing test (DBT) + sequential standard BP measurement
Number of subjects: 214

Group type: COMPARATOR
Intervention: Sequential standard BP measurement only
Number of subjects: 214
Study: 23312003

Group type: EXPERIMENTAL
Intervention: Low intensity Internet-delivered psychotherapy + improved treatment as usual (ITAU) by GP
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Self-guided Internet-delivered psychotherapy + ITAU
Number of subjects: 450

Group type: COMPARATOR
Intervention: ITAU
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Low intensity Internet-delivered psychotherapy + ITAU
Number of subjects: 450
Study: 21658716

Group type: EXPERIMENTAL
Intervention: Miglustat treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17477451

Group type: EXPERIMENTAL
Intervention: Life Review Group Program (LRGP) for 8 weeks
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 75
Study: 16506965

Group type: EXPERIMENTAL
Intervention: 100% fish oil (FO)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 100% rapeseed oil (RO)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 50% fish oil / 50% rapeseed oil (FO/RO)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 58
Study: 12949360

Group type: EXPERIMENTAL
Intervention: 6 isoenergetic meals every 4 hours (N-eat)
Number of subjects: 7

Group type: COMPARATOR
Intervention: 4 isoenergetic meals from 0800 to 2000 h followed by a nocturnal fast (N-fast)
Number of subjects: 7

Group type: COMPARATOR
Intervention: N-fast
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: N-eat
Number of subjects: 7
Study: 10896700

Group type: COMPARATOR
Intervention: Melancholic patients with no reduction in external cues
Number of subjects: 48

Group type: COMPARATOR
Intervention: Melancholic patients with moderate reduction in external cues
Number of subjects: 48

Group type: COMPARATOR
Intervention: Melancholic patients with high reduction in external cues
Number of subjects: 48

Group type: COMPARATOR
Intervention: Non-melancholic patients with high reduction in external cues
Number of subjects: 48

Group type: COMPARATOR
Intervention: Controls with high reduction in external cues
Number of subjects: 48
Study: 8884424

Group type: EXPERIMENTAL
Intervention: 40% VO2peak exercise
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 60% VO2peak exercise
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 70% VO2peak exercise
Number of subjects: 15